Previous Article | Next Article ![]()
Journal of Bacteriology, December 2006, p. 8054-8061, Vol. 188, No. 23
0021-9193/06/$08.00+0 doi:10.1128/JB.00935-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Institute of Biotechnology, Research Centre Juelich, D-52425 Juelich, Germany,1 Degussa R&D Feed Additives/Biotechnology, P.O. Box 1112, D-33788 Halle, Germany,2 Institute of Molecular Microbiology and Biotechnology, University of Münster, Corrensstrasse 3, D-48149 Münster, Germany3
Received 28 June 2006/ Accepted 18 September 2006
|
|
|---|
|
|
|---|
![]() View larger version (19K): [in a new window] |
FIG. 1. Assumed pathway for myo-inositol degradation. The pathway is in part speculative and largely based on enzymological studies of K. aerogenes (2, 19), studies of B. subtilis (27-30), and genome comparisons. The genes and the enzymes encoded are given; those with a presumed assignment are in parentheses.
|
We are interested in Corynebacterium glutamicum, an apathogenic bacterium of industrial interest used for the large-scale production of amino acids, in particular, L-glutamate and L-lysine (8). Together with Mycobacterium tuberculosis, for instance, this bacterium belongs to the suborder Corynebacterineae, characterized among others by possessing myo-inositol as a cellular building block, as is the case in eukaryotes (20, 22). The inositol is required for the synthesis of phosphatidyl-myo-inositol, which is an abundant phospholipid in the cytoplasmic membrane and which in turn is also a precursor of more-complex cellular glycolipids in Corynebacterineae such as lipomannans and lipoarabinomannans (5). Furthermore, myo-inositol is also a building block for mycothiol (5, 7, 22), which is a low-molecular-mass thiol specific to Corynebacterineae and necessary for protection against the damaging effects of reactive oxygen species, similar to glutathione in eukaryotes and gram-negative bacteria. In C. glutamicum, we detected a number of genes annotated as iol and wished to know whether their presence enables C. glutamicum to grow on this polyol with an additional focus on the transport of myo-inositol and the physiological consequences of its utilization.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains, plasmids, and oligonucleotides used in this study
|
Preparation of total RNA and DNA microarray analyses. Cultures were grown in CGXII minimal medium containing 40 g liter1 myo-inositol or glucose. In the exponential growth phase at an OD600 of 4 to 6, 25 ml of each culture was used for the preparation of total RNA as previously described (27). Isolated RNA samples were analyzed for quantity and quality by UV spectrophotometry and denaturing formaldehyde agarose gel electrophoresis (21), respectively, and stored at 70°C until use. The generation of whole-genome DNA microarrays, synthesis of fluorescently labeled cDNA from total RNA, microarray hybridization, washing, and data analysis were performed as described previously (27). Genes that exhibited significantly changed mRNA levels (P < 0.05 by Student's t test) by at least a factor of 2.8 were determined in independent growth experiments with subsequent hybridizations (Table 2).
|
View this table: [in a new window] |
TABLE 2. Genes of C. glutamicum whose average mRNA ratio was altered 2.8-fold (P 0.05) in myo-inositol-grown cells compared to that in glucose-grown cells in at least three independent cultivations
|
|
|
|---|
![]() View larger version (14K): [in a new window] |
FIG. 2. Growth of C. glutamicum WT and mutants generated in this study on myo-inositol and glucose. (A) Growth of the WT on 4% glucose ( ), on 4% myo-inositol ( ), and on a mixture (2% plus 2%) of the two sugars ( ). (B) Growth of the iolD mutant on myo-inositol ( ) and glucose ( ). Growth of the oxiII mutant ( ), the piolG' mutant ( ), and the oxiII::piolG' double mutant ( ) on myo-inositol is compared to that of the WT on myo-inositol ( ). (C) Growth of the transporter deletion mutants iolT1 ( ), iolT2 ( ), and iolT1 iolT2 ( ) compared to that of the WT on myo-inositol ( ).
|
The most strongly reduced mRNA level during growth on myo-inositol was determined for the myo-inositol-1-phosphate synthase gene, ips (20). This gene is required in Corynebacterineae for glucose 6-phosphate conversion to myo-inositol, which is a constituent of mycothiol and phosphatidyl-myo-inositol. A regulation of ips is not yet known, but its repression is consistent with the fact that an external supply of myo-inositol makes its cellular synthesis dispensable.
Twenty-one genes showed an up to 18-fold increase in mRNA level, indicative of a possible function within myo-inositol catabolism (Table 2). All but one of these genes are located in two large clusters. The exception is NCgl2865, predicted to encode a secreted protein containing three copper oxidase-like domains. The genome organization of the two clusters is given in Fig. 3, where genes which showed a
2.8-fold increase in mRNA level are marked in black. The core of cluster I spans about 16 kb and comprises 13 genes (Fig. 3). It partly resembles the iol cluster of B. subtilis (29), and the iol gene annotations were used according to that introduced for this organism, although definite functions are unknown in almost all cases. The mRNA level of NCgl0156, located between iolC and iolA, was also slightly increased but less than 2.8-fold. An orthologue of this gene is not present in B. subtilis. It is most likely that the 10 genes of C. glutamicum from iolC to oxiA are cotranscribed as an operon. In contrast, the LacI-type regulator encoded by NCgl0167 (Reg1 in Fig. 3) and divergently transcribed oxiB, as well as remotely located iolT1, all three with an mRNA level of
7, might be separately transcribed.
![]() View larger version (9K): [in a new window] |
FIG. 3. Genome maps of the C. glutamicum regions functioning in myo-inositol catabolism. Cluster I shows the genome organization of the nucleotide sequence from 167,768 to 193,453, and cluster II shows the sequence from 3,257,372 to 3,272,564 of the C. glutamicum genome NC_003450. Genes exhibiting a 2.8-fold increase in the mRNA ratio during growth on myo-inositol compared to glucose are in black. Below cluster II, the two genomic deletions oxiII and iolII, respectively, are indicated. The values on the scale bar are in kilobases.
|
2.8-fold increase in mRNA level. Only the level of the putative regulator gene iclR, located in front of the cluster of genes encoding three oxidoreductases, was not increased during growth on myo-inositol. We also wanted to know whether mRNA levels of cells grown on complex medium consisting of brain heart extract (BHI) also influence iol gene expression and compared the mRNA levels of cells grown on BHI with those of cells grown on CGXII salt medium containing glucose (Table 2). Indeed, a number of iol genes responded and ips was downregulated, suggesting that inositol utilization is part of cell mass generation during growth on the complex medium BHI. This is in agreement with the detection of two Iol proteins of C. glutamicum grown on complex medium (15).
Characterization of selected iol mutants.
The large number of genes apparently related to myo-inositol catabolism in C. glutamicum is intriguing. Unfortunately, functional studies of enzymes and genes of inositol metabolism are scarce (Fig. 1). However, cleavage of the putative intermediate 2-deoxy-5-keto-D-gluconic acid is considered a key step in myo-inositol metabolism, as shown in the early studies of K. aerogenes by Anderson and Magasanik (2). Since cleavage of
-ketols in carbohydrate metabolism is typically performed by thiamine-pyrophosphate-dependent enzymes and the iolD gene product of C. glutamicum possesses a corresponding binding site (not shown), a vector was constructed to delete this gene from the wild type (WT) of C. glutamicum (see Materials and Methods). The resulting mutant, WT
iolD, was unable to grow on myo-inositol, whereas growth on glucose was hardly affected (Fig. 2B). Thus, iolD within cluster I is essential for myo-inositol utilization by C. glutamicum.
As many as six genes for oxidoreductases have increased expression levels upon myo-inositol utilization. PFAM analysis (3) identified three oxidoreductases (iolG, oxiA, oxiB) within cluster I and an additional three in cluster II (oxiC, oxiD, oxiE). Since a iolG orthologue is present within the B. subtilis iol operon (39% identities), we inactivated the orthologue to generate strain WT::piolG'. As shown in Fig. 2B, its growth on inositol was reduced compared to that of the control but was still possible. Therefore, we considered that one of the other oxidoreductases might partially substitute for the function of iolG. IolG exhibits identities of 27% to OxiE, 22% to OxiD, and still 19% to OxiC over the entire lengths of the proteins, whereas identities to OxiA and OxiB were significantly less. The oxidoreductase encoded by idhA of S. meliloti (11) is, apart from iolE of B. subtilis (31), the only functionally identified gene of bacterial inositol metabolism, and OxiE, OxiD, and OxiC in cluster II exhibit high identities to IdhA but low identities to OxiA and OxiB. We therefore considered that the three oxidoreductases in cluster II might have some overlapping activity with the function of iolG and constructed plasmid pK19mobsacB
oxiII to delete the 4.072-kb region of cluster II encompassing oxiC to oxiE (Fig. 3). The growth of generated strain WT
oxiII is shown in Fig. 2B. Growth on neither inositol nor glucose (not shown) was influenced by the deletion. We subsequently inactivated iolG in the strain with the four genes of cluster II deleted to generate WT
oxiII::piolG'. This strain was no longer able to grow on myo-inositol. This result indicates that the genes of cluster II play a subordinate role in myo-inositol utilization and that apparently a number of overlapping oxidoreductase activities exist in C. glutamicum which can be used to enable growth on this carbon source. Due to the growth characteristics of WT
oxiII::piolG', we hypothesized that further genes of cluster II might be redundant or unnecessary for myo-inositol utilization. To this end, plasmid pK19mobsacB
iolII was constructed and the 8.799-kb chromosomal region extending from adhA to oxiE (Fig. 3) was deleted to generate WT
iolII. Growth on myo-inositol was not reduced by this deletion either (not shown), which indicates that cluster II is dispensable for myo-inositol metabolism and that the corresponding genes might play an as-yet-undiscovered role or indicate ongoing evolution although the data show that they are at least in part functional.
Characterization of transporter mutants.
There are three carrier genes which exhibit an at least 12-fold increase in the mRNA level upon myo-inositol utilization: mfs in cluster I, remote gene iolT1, and iolT2 in cluster II (Fig. 3). All transporters belong to the major facilitator superfamily and exhibit identities to sugar transporters or, in the case of mfs, also identities to annotated efflux carriers. The presence of three transporters resembles the situation in B. subtilis, which possesses two transporters for inositol uptake (28). To move toward an analysis of the function of the transporters in C. glutamicum, we inactivated each of these three genes individually in strain ATCC 21527, an L-lysine producer, but growth was not hampered on CGXII plates containing as a carbon source sorbitol, glucose, ribose, fructose, arabitol, gluconate, or saccharose (each at 40 g literl) compared to that of controls (not shown). Following this observation, we deleted the transporter genes iolT1 and iolT2 in C. glutamicum strain ATCC 13032 (WT) individually and together. The growth of the resulting strains is shown in Fig. 2C. Whereas the growth of WT
iolT1 and WT
iolT2 on myo-inositol or glucose was not influenced, the growth of WT
iolT1
iolT2 on myo-inositol was disabled but its growth on glucose was not. Consequently, both the iolT1- and iolT2-encoded carriers appear to catalyze inositol uptake, whereas mfs1, although located within the putative iolA-oxiA operon (Fig. 3), does not.
Kinetic characterization of IolT1 and IolT2.
Cells were grown on CGXII with myo-inositol up to an OD600 of about 4 to 6, washed twice with CGXII without a carbon source, and stored on ice to quantify myo-[1,2-3H]inositol uptake in a rapid filtration assay. Saturation curves were obtained from the initial linear uptake rate (at least three data points over 40 s) at each substrate concentration. For the WT, nonlinear regression analysis yielded an apparent Michaelis constant (Km) of 0.20 ± 0.04 mM myo-inositol concentration and a Vmax value of 3.79 ± 0.19 nmol min1 (mg cells)1 (Fig. 4). The mutants with individually deleted IolT1 or IolT2 were analyzed in an identical manner. Assuming that in WT
iolT2 only IolT1 is active, as is indicated by the inability of the double mutant to utilize myo-inositol, IolT1 is characterized by a Km of 0.22 ± 0.04 mM myo-inositol and a Vmax value of 1.22 ± 0.05 nmol min1 (mg cells)1 and IolT2 is characterized by a Km of 0.45 ± 0.09 mM myo-inositol and a Vmax value of 2.90 ± 0.18 nmol min1 (mg cells)1. Thus, both carriers have comparable kinetic constants, which is probably not surprising since both share a high degree of identity of 55%, although two insertions of up to 15 aminoacyl residues are present in IolT1.
![]() View larger version (15K): [in a new window] |
FIG. 4. Substrate saturation kinetics of myo-inositol uptake with C. glutamicum. Uptake of myo-[1,2-3H]inositol by C. glutamicum cells was monitored between myo-inositol concentrations of 0.05 and 5 mM for 55 s in CGXII by the rapid-filtration technique. From the initial uptake rate at each substrate concentration, the Michaelis-Menten plots were derived by nonlinear regression analysis. Uptake by the WT ( ), the iolT1 mutant ( ), and the iolT2 mutant () is shown.
|
|
View this table: [in a new window] |
TABLE 3. L-Lysine formation with C. glutamicum strain DM1730 as a function of the substrates glucose and myo-inositol and mixtures of these substrates
|
|
|
|---|
The number of genes exhibiting increased expression upon myo-inositol catabolism was puzzling at the beginning of our work, in particular since knowledge of myo-inositol utilization in general is rather limited. Thus, according to the array analysis, in principle, as many as six oxidoreductases could be required for myo-inositol utilization, as well as three transporters and two isomerase-epimerases (Table 2). However, the deletion of all of cluster II and growth of the corresponding mutant WT
iolII are strong evidence that cluster II encodes redundant functions of myo-inositol utilization as specifically demonstrated for uptake and oxidation steps within the catabolism of the polyol. Moreover, the genomic region of cluster II encompassing the adjacent catA-adh region exhibits amazingly high identities at the nucleotide level of up to 74% to NCgl1112 and NCgl1113, located elsewhere in the chromosome, showing that gene duplication within C. glutamicum might also be involved in the formation of cluster II. Also the high identity of 30% between oxiD and oxiE at the protein level and even at the nucleotide level (not shown) illustrates that this genomic region does not belong to regions encoding conserved cellular core functions like cell wall synthesis, for instance (1, 12). Instead, this region appears to be rather the result of a more recent event of genome alteration. This is in full accord with the absence of iol genes in C. efficiens, C. diphtheriae, and C. jeikeium indicating a specific and fortuitous acquisition of these genes by C. glutamicum.
Cluster I encodes relevant functions for myo-inositol catabolism in C. glutamicum, as evident from the consequences of iolD inactivation and the iolG mutation in the
oxiII background. As evident from the early biochemical work of Magasanik and coworkers (2, 19), myo-inositol catabolism might involve oxidative steps, epimerization, phosphorylation of a linear diketo-deoxy-inositol, cleavage, and a further oxidative step to yield acetyl-CoA and dihydroxyacetone-P (Fig. 1). Interestingly, orthologues of six genes of cluster I are present and largely syntenic to the organization of C. glutamicum in B. subtilis (29), B. halodurans, Clostridium perfringens (17), and Yersinia pseudotuberculosis. Therefore, these genes are likely to encode the key functions to catabolize myo-inositol, as discussed in detail by Magasanik. This relates to iolG and iolE, whose functions have been identified (10, 31); to iolC, whose structural characteristics according to PFAM analysis (3) indicate that it encodes a 5-dehydro-2-deoxygluconokinase; iolD, which encodes a thiamine pyrophosphate-dependent enzyme typically cleaving sugar phosphates; and iolA, which encodes an aldehyde dehydrogenase. The iolB-encoded protein is also conserved but does not have a PFAM entry, consequently representing a protein with no structural counterpart in the current databases. The initial oxidative steps to form a cleavable diketo intermediate from myo-inositol might differ among the bacteria. At least the genome comparisons did not allow us to specify a core requirement for oxidoreductases.
Uptake of myo-inositol to sustain maximal growth is possible by either IolT1 or IolT2, and the genes for both are expressed to similar degrees (Table 2). They also have comparable kinetic properties, which is probably not surprising due to their high sequence identity of 55%. The IolT proteins are 12-membrane spanners belonging to the major facilitator superfamily. Also, B. subtilis has two inositol uptake carriers that are similar in structure, but these share fewer sequence identities than do the C. glutamicum proteins. In marked contrast to C. glutamicum, in B. subtilis neither transporter can be substituted for the other since they represent a minor and a major myo-inositol transporter (28). It is surprising that the third transporter of C. glutamicum analyzed in the present study is part of cluster I but nevertheless is not involved in myo-inositol uptake. Instead, it shares identities with efflux pumps, indicating together with its absence in the iol locus of other bacteria, its fortuitous presence in cluster I.
The L-lysine formation data showed a reduced yield with myo-inositol as a carbon source compared to glucose. It is known that the amino acid yield strongly depends on the type of substrate. The highest L-lysine yields with C. glutamicum are obtained with glucose, and the lowest are obtained with fructose (13, 18). Thus, myo-inositol ranks among the substrates giving rather low yields. This could be due to the fact that pyruvate and oxaloacetate, required as building blocks for L-lysine, probably do not result from myo-inositol catabolism (2, 19). Surprising is the fact that there is a significant yield reduction when myo-inositol is present at relatively low supplementary concentrations in addition to glucose. Although myo-inositol contributes about 8% of the total carbon in a mixture with glucose, the resulting yield is reduced by as much as 29% (Table 3). The effect of cells grown in different complex media and used as inoculum on the final yield is well established (25), and the present study, as well as a proteome study (15), shows that iol genes are expressed on complex media usually used to derive the inoculum. However, in our experiments the preculture medium for deriving the inoculum was identical to the culture medium where the yields were determined. We envisage two possibilities. Although we did no DNA microarray analysis for cells grown on a glucose-inositol mixture, myo-inositol undoubtedly affects expression of genes of central metabolism, like components of the phosphotransferase system (see above), as well as mez, malic enzyme, or sucC, encoding a succinyl-CoA synthetase subunit (Table 2). Moreover, enzyme activities could be influenced by different metabolite concentrations. The other possibility is that due to the presence of myo-inositol the cell wall and its lipomannan composition are influenced so as to reduce L-lysine export. It is known that in C. glutamicum the cellular lipid composition influences amino acid efflux properties (6).
Published ahead of print on 22 September 2006. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»